NewAmsterdam Pharma Company N.V.

NAMS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$22.49+2.55%

2026-09-18

Financials

Valuation Metrics

NewAmsterdam Pharma Company N.V.'s Market Cap is $2.63B. At end of 2025 it was $4.01B. Ranked #1854 of 3,121 in US market (top 59%), #681 of 1,463 on NASDAQ (top 47%), #114 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 43%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$2.63B	US#1,854/3,121 Sec#114/266
Revenue	$7M	US#2,844/3,121 Sec#175/266
Net Income	$-260M	US—/3,121 Sec—/266
Total Assets	$704M	US#2,624/3,121 Sec#130/266
Net Assets	$631M	US#2,081/3,121 Sec#92/266
Value
P/B	4.16x	US#2,032/3,121 Sec#118/266
P/S	369.21x	US#2,972/3,121 Sec#191/266
FCF Yield	-5.47%	US—/3,121 Sec—/266
Profitability
ROE	-41.10%	US#2,638/3,121 Sec#138/266
ROA	-36.84%	US#2,930/3,121 Sec#179/266
Op. Margin	-3432.20%	US#2,851/3,121 Sec#175/266
Revenue Growth	-88.87%	US#2,768/3,121 Sec#181/266
Financial Health
Debt Ratio	11.57%	US#129/3,121 Sec#57/266
Total Debt	$82000.00	US#3,023/3,121 Sec#261/266
FCF	$-144M	US#2,710/3,121 Sec#174/266
Cash	$424M	US#1,179/3,121 Sec#64/266
Current Ratio	9.03x	US#291/3,121 Sec#87/266
Performance
1Y Return	-15.86%	US#2,135/3,121 Sec#204/266
1M Return	-21.17%	US#2,966/3,121 Sec#240/266
From 52W High	-46.72%	US#2,665/3,121 Sec#209/266
1Y MDD	-48.95%	US#2,418/3,121 Sec#176/266
Trading
Volume	2,041,095 shares	US#744/3,121 Sec#75/266
Trading Value	$45M	US#1,252/3,121 Sec#93/266
Per Share
EPS	$-2.22	US—/3,121 Sec—/266
BPS	$5.40	US#2,252/3,121 Sec#124/266